Korean company to launch cancer diagnosis kit:
This article was originally published in Clinica
Executive Summary
Hanmi Pharmaceuticals is preparing to launch a home blood test kit which claims to diagnose gastric, lung, colorectal and breast cancer. The four-hour long test claims "up to" 94.7% accuracy, by measuring levels of TGF-beta - a growth factor correlated with the early presence of cancers. Hanmi plans to launch the kit this year in Korea and is applying for international patents.